0202411110603: Difference between revisions

From STARDIT
Jump to navigation Jump to search
No edit summary
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{item
{{item
|title=Medical Services Advisory Committee - Expert Standing Committees
|title=Medical Services Advisory Committee - Evaluation Sub-committee (ESC)
|type_parameter=research
|type_parameter=research
|description_parameter=The Medical Services Advisory Committee (MSAC) has several Expert Standing Committees (ESCs) which provide specialist advice and make recommendations to the MSAC on a range of medical services and technologies. The ESCs are composed of experts in various fields of medicine and health technology assessment.
|description_parameter=The Medical Services Advisory Committee (MSAC) has several Evaluation Sub-committee (ESC) provides specialist advice and makes recommendations to the MSAC on a range of medical services and technologies. The ESCs are composed of experts in various fields of medicine and health technology assessment.
|aim_parameter={{aim parameter|provide specialist advice to the MSAC}}{{aim parameter|make recommendations on medical services and technologies}}{{aim parameter|assist in the assessment of the safety, clinical effectiveness, and cost-effectiveness of medical services}}
|aim_parameter={{aim parameter|provide specialist advice to the MSAC}}{{aim parameter|make recommendations on medical services and technologies}}{{aim parameter|assist in the assessment of the safety, clinical effectiveness, and cost-effectiveness of medical services}}
|keyword_parameter={{keyword parameter|medical services}}{{keyword parameter|health technology}}{{keyword parameter|assessment}}{{keyword parameter|advice}}
|keyword_parameter={{keyword parameter|medical services}}{{keyword parameter|health technology}}{{keyword parameter|assessment}}{{keyword parameter|advice}}
Line 30: Line 30:
|con_cop=paid
|con_cop=paid
|con_dates=No
|con_dates=No
}}{{contributor parameter
|con_typ=individual
|con_nam=Professor Kwun Fong
|con_tas=Chairing meetings
|con_url=https://orcid.org/0000-0002-6507-1403
|con_ids=https://orcid.org/0000-0002-6507-1403
|con_met=Appointed as Chair
|con_cop=paid
|con_dates=No
|con_des=Information correct as of 15/10/2024 - http://www.msac.gov.au/internet/msac/publishing.nsf/Content/esc-membership
}}
}}
|output_parameter={{output parameter
|output_parameter={{output parameter

Latest revision as of 13:23, 15 November 2024

Medical Services Advisory Committee - Evaluation Sub-committee (ESC) Description: The Medical Services Advisory Committee (MSAC) has several Evaluation Sub-committee (ESC) provides specialist advice and makes recommendations to the MSAC on a range of medical services and technologies. The ESCs are composed of experts in various fields of medicine and health technology assessment.
STARDIT ID: 0202411110603
Dates

State ongoing
Start 1998-01-01
Form updated 2024-11-15

Report authors
Jack Nunn (link)
0000-0003-0316-3254
Aims
provide specialist advice to the MSAC
make recommendations on medical services and technologies
assist in the assessment of the safety, clinical effectiveness, and cost-effectiveness of medical services
Keywords
medical services
health technology
assessment
advice
Category
research

Inputs

organisation

Department of Health (link)



Task: Funding, providing resourcing for organisation and Secretariat support
group of individuals

Expert Standing Committee Members (varies) (link)



Task: Assess items
Compensation: paid
individual

Professor Kwun Fong (link)



ID: https://orcid.org/0000-0002-6507-1403
Task: Chairing meetings
Method: Appointed as Chair
Compensation: paid


Information correct as of 15/10/2024 - http://www.msac.gov.au/internet/msac/publishing.nsf/Content/esc-membership

Outputs and impacts

other

Application decisions (link)



Impact: Impacts and informs Federal Government decision-making on health technology assessment, by providing advice to Government on whether a new medical service should be publicly funded (and if so, its circumstances) on an assessment of its comparative safety, clinical effectiveness, cost-effectiveness, and total cost, using the best available evidence.